
Asarfi Hospital reported a year-on-year increase in net sales for March 2026, with consolidated sales rising 33.49% to Rs 45.24 crore and standalone sales up 32.88% to Rs 45.03 crore. Quarterly net profit increased to Rs 3.92 crore consolidated and Rs 4.09 crore standalone. EBITDA declined by approximately 15% in both reports. Earnings per share rose to Rs 1.99 consolidated and Rs 2.08 standalone. Shares closed at Rs 252.80 on May 8, 2026.
The articles focus on financial performance metrics without political framing. Both consolidated and standalone results are presented factually, reflecting corporate financial reporting norms. There is no evident political perspective or ideological framing in the coverage.
The tone across the articles is neutral to mildly positive, highlighting growth in sales and profits while noting declines in EBITDA. The coverage balances positive financial gains with the decrease in earnings before interest, taxes, depreciation, and amortization, maintaining an objective stance.
Each source's own headline, political lean, and sentiment — so you can see framing differences at a glance.
| Source | Their headline | Bias | Sentiment |
|---|---|---|---|
| moneycontrol | Asarfi Hospital Standalone March 2026 Net Sales at Rs 45.03 crore, up 32.88 Y-o-Y- Moneycontrol.com | Center | Neutral |
| moneycontrol | Asarfi Hospital Consolidated March 2026 Net Sales at Rs 45.24 crore, up 33.49 Y-o-Y- Moneycontrol.com | Center | Neutral |
moneycontrol broke this story on 11 May, 03:20 pm. Other outlets followed.
Well-covered story — coverage matches public importance.
Institutions and figures named across source coverage.
Select a news story to see related coverage from other media outlets.